v3.26.3
UNAUDITED CONDENSED STATEMENT OF CASH FLOWS - USD ($)
 2 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2026
Cash flows from operating activities:    
Net income/(loss) $ (38,180) $ 1,912,334
Adjustments to reconcile net income/(loss) to net cash used in operating activities    
Allocated expense for warrant issuance cost 0 270,678
Interest income from trust account 0 (3,479,479)
Loss from change in fair value of public warrant liabilities 0 897,000
Changes in operating assets and liabilities:    
Changes in prepaid expenses (11,461) (489,426)
Accrued expenses, formation and offering costs 49,641 35,953
Net cash used in operating activities 0 (852,940)
Cash flows from investing activities:    
Cash deposited in Trust Account 0 (358,800,000)
Net cash used in investing activities 0 (358,800,000)
Cash flows from financing activities:    
Proceeds from sale of Units in initial public offering 0 358,800,000
Proceeds from sale of Private Placement Shares to Sponsor 0 2,250,000
Payment of accrued offering costs 0 (683,110)
Payment of underwriter's discounts and commissions 0 (250,000)
Proceeds from notes payable - related party 0 166,327
Repayment of notes payable - related party 0 (236,120)
Net cash provided by financing activities 0 360,047,097
Net change in cash 0 394,157
Cash at beginning of period 0 0
Cash at end of period 0 394,157
Supplemental disclosure of non-cash financing activities:    
Offering costs included in accrued expenses 0 30,061
Advisory fee 0 10,764,000
Deferred underwriting compensation 0 10,764,000
Offering costs charged to additional paid in capital 0 1,025,117
Initial classification of warrant liability - public 0 4,305,600
Deferred offering costs included in accrued expenses 191,901 0
Deferred offering costs paid by Sponsor included in note payable - related party 69,793 0
Prepaid expenses paid by Sponsor in exchange for issuance of Class B ordinary shares $ 25,000 $ 0